Glaukos GKOS
NYSE GKOS
$188.35 -1.20 (-0.63%)
At close: Aug 20, 2026 · 1:07 PM UTC

Glaukos (GKOS) Non-Current Debt (2014 - 2015)

Glaukos (GKOS) posted quarterly Non-Current Debt of $765000.0 for Q4 2015, down 91.47% year-over-year from $9.0 million in Q4 2014, and down 74.83% quarter-over-quarter from $3.0 million in Q3 2015.

Glaukos (GKOS) Non-Current Debt (2014 - 2015) Analysis & Trends

Glaukos (GKOS) has reported Non-Current Debt for 2 consecutive years, with $765000.0 the latest figure, recorded in Q4 2015.

  • In Q4 2015, Non-Current Debt fell 91.47% year-over-year to $765000.0; the TTM figure through Dec 2015 stood at $765000.0 (down 91.47% YoY), while the FY2015 annual figure was $765000.0, down 91.47% from the prior year.
  • Non-Current Debt declined to $765000.0 in Q4 2015 per GKOS's latest filing, from $3.0 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $11.6 million in Q2 2015 and bottomed at $765000.0 in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 199.12 Bn 193.52 Bn 7.27 Bn 29.60 Bn
2 Stryker 128.79 Bn 125.32 Bn 4.50 Bn 14.19 Bn
3 Medtronic 119.30 Bn 110.08 Bn 6.41 Bn 26.17 Bn
4 Boston Scientific 73.50 Bn 72.96 Bn 3.85 Bn 10.92 Bn
5 Edwards Lifesciences 52.11 Bn 47.86 Bn 1.35 Bn 598.70 Mn
6 Dexcom 34.62 Bn 32.67 Bn 830.00 Mn -
7 GE HealthCare Technologies 34.05 Bn 31.94 Bn 2.18 Bn 10.09 Bn
8 Koninklijke Philips 26.42 Bn 23.10 Bn 4.55 Bn 7.34 Bn
9 Steris 23.15 Bn 22.67 Bn 684.20 Mn 1.65 Bn
10 Glaukos 11.07 Bn 10.96 Bn 151.59 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2015 765,000.00
Sep 30, 2015 3.04 Mn
Jun 30, 2015 11.64 Mn
Dec 31, 2014 8.97 Mn